PMID- 10381371 OWN - NLM STAT- MEDLINE DCOM- 19990729 LR - 20061115 IS - 0006-291X (Print) IS - 0006-291X (Linking) VI - 260 IP - 1 DP - 1999 Jun 24 TI - Hepatocyte growth Factor/Scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: comparison between the effects of HGF/SF and TGF-beta1 on fibronectin splicing at the EDA region. PG - 225-31 AB - EDA-containing fibronectin (EDA + FN) is selectively produced under several physiological and pathological conditions requiring tissue remodeling, where cells actively proliferate and migrate. Only a few growth factors, such as transforming growth factor (TGF)-beta1, have been reported to regulate FN splicing at the EDA region. In the present study, we showed for the first time that hepatocyte growth factor/scatter factor (HGF/SF), which is mainly produced by mesenchymal cells and functions as a motogenic and mitogenic factor for epithelial cells, modulates FN splicing at the EDA region in MDCK epithelial cells. HGF/SF treatment increased the ratio of EDA + FN mRNA to mRNA of FN that lacks EDA (EDA - FN) (EDA+/EDA- ratio) more than TGF-beta1 treatment did: at a range from 0.02 to 20 ng/ml, HGF/SF increased the ratio in a dose-dependent manner by up to 2. 1-fold compared with nontreated control, while TGF-beta1 stimulated the EDA+/EDA- ratio by 1.5-fold at the optimum dose of 10 ng/ml. However, TGF-beta1 increased total FN mRNA levels by 3-fold at 10 ng/ml, but HGF/SF did not. We previously demonstrated that fibroblasts cultured at low cell density expressed more EDA + FN than those at high cell density. The same effect of cell density was also observed in MDCK cells. Furthermore, at low cell density, HGF/SF stimulated EDA inclusion into FN mRNA more effectively than did TGF-beta1, whereas at high cell density, TGF-beta1 was more potent than HGF/SF. Simultaneous treatment of cells with HGF/SF and TGF-beta1 synergistically stimulated EDA inclusion into FN mRNA. This stimulation of EDA inclusion into FN mRNA by HGF/SF led to increased EDA + FN protein production and secretion by cells, which was demonstrated by immunoblotting. Thus, our studies have shown that HGF/SF is an enhancer of EDA inclusion into FN mRNA as is TGF-beta1. However, these two factors were different in their effects at low and high cell densities and also in their effects on total FN mRNA levels. CI - Copyright 1999 Academic Press. FAU - Inoue, T AU - Inoue T AD - Second Department of Pathology, Miyazaki Medical College, 5200 Kihara, Miyazaki, Kiyotake, 889-1692, Japan. FAU - Nabeshima, K AU - Nabeshima K FAU - Shimao, Y AU - Shimao Y FAU - Koono, M AU - Koono M LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (EDA protein, human) RN - 0 (Ectodysplasins) RN - 0 (Fibronectins) RN - 0 (Membrane Proteins) RN - 0 (Transforming Growth Factor beta) RN - 67256-21-7 (Hepatocyte Growth Factor) SB - IM MH - Animals MH - Cell Count MH - Cell Line MH - Dogs MH - Dose-Response Relationship, Drug MH - Ectodysplasins MH - Fibronectins/*metabolism MH - Hepatocyte Growth Factor/pharmacology/*physiology MH - Humans MH - Membrane Proteins/*pharmacology MH - Reverse Transcriptase Polymerase Chain Reaction MH - Transforming Growth Factor beta/*pharmacology EDAT- 1999/06/25 00:00 MHDA- 1999/06/25 00:01 CRDT- 1999/06/25 00:00 PHST- 1999/06/25 00:00 [pubmed] PHST- 1999/06/25 00:01 [medline] PHST- 1999/06/25 00:00 [entrez] AID - S0006-291X(99)90881-1 [pii] AID - 10.1006/bbrc.1999.0881 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 1999 Jun 24;260(1):225-31. doi: 10.1006/bbrc.1999.0881.